본문으로 건너뛰기
← 뒤로

Pancreatitis induced by Peg-aspargase in children: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS).

1/5 보강
Leukemia research reports 📖 저널 OA 100% 2025: 1/1 OA 2026: 23/23 OA 2025~2026 2026 Vol.25() p. 100562 OA
Retraction 확인
출처

Zhang W, Luo B, Liu Z, Mi J, Yang Y, Li Y

📝 환자 설명용 한 줄

This study analyzed FAERS data to evaluate pegaspargase safety in pediatric acute lymphoblastic leukemia treatment.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Zhang W, Luo B, et al. (2026). Pancreatitis induced by Peg-aspargase in children: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS).. Leukemia research reports, 25, 100562. https://doi.org/10.1016/j.lrr.2026.100562
MLA Zhang W, et al.. "Pancreatitis induced by Peg-aspargase in children: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS).." Leukemia research reports, vol. 25, 2026, pp. 100562.
PMID 41608134 ↗

Abstract

This study analyzed FAERS data to evaluate pegaspargase safety in pediatric acute lymphoblastic leukemia treatment. Among 21,161,817 reports, 847 identified pegaspargase as the primary suspect drug, revealing adverse events (AEs) across 26 organ systems. Disproportionality analysis identified four previously unlisted AEs. Critically, pegaspargase-associated pancreatitis incidence showed significant age-dependence (χ²=8.219, < 0.05). These findings address the knowledge gap in real-world, long-term pediatric safety profiles and provide crucial clinical references for safer medication use in children.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기